- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05384067
Project MiCRIM- Sleep and Stress Intervention
July 24, 2023 updated by: Scott Pickett, Florida State University
Defining Stress and Sleep as Modifiable Intervention Targets in Correctional Officers to Reduce Mental and Physical Health Risk
The purpose of Project MiCRIM is to test the feasibility and effectiveness of an online 4-week mindfulness-based intervention that incorporates informational elements about sleep, mindfulness, thoughts, emotions, and acceptance using a control sample of Criminology and Criminal Justice majors as a proxy for Corrections officers.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The study will use a waitlist-control design to examine the effectiveness of a brief (4-week) online mindfulness-based intervention aimed at reducing stress and improving sleep quality.
A proxy, convenience sample of 50 criminology majors will be recruited and randomized into the active intervention or waitlist condition.
The intervention requires participants to complete one mindfulness education module every week for 4 weeks, and to practice a 15-minute formal guided mindfulness meditation at least five times per week across the 4 weeks.
Participants will also be taught evidence-based sleep improvement techniques, will be provided education for when to use the techniques, and will be encouraged to implement the techniques to improve sleep.
Validated self-report measures of stress, anxiety, mood, and sleep quality will be assessed pre- and post-intervention.
Adherence to the mindfulness practice will be monitored online and self-report assessments of sleep technique implementation will be collected.
Sleep patterns will be assessed using a Philips Respironics Spectrum 2 Actiwatch, which is a wrist-worn device that measures movement and light exposure and estimates sleep-wake patterns.
Lastly, multiple saliva samples pre- and post-intervention will be collected and analyzed by ELISA with a multiplex cytokine assay.
Cortisol, α-amylase, and the four analytes with known deleterious roles in cellular and behavioral stress responsiveness will be measured simultaneously: interleukin-1beta, interleukin-6, interleukin-8, and Tumour Necrosis Factor-alpha will be examined pre- and post-intervention.
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Tallahassee, Florida, United States, 32310
- Florida State University Center for Translational Behavioral Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 24 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
-Criminal Justice or Criminology major
Exclusion Criteria:
- Abnormal BMI (below 18.5 or above 30)
- self-reported sleep apnea, head injury, neurological problem, unstable mental health disorder, substance use disorder, psychosis, or current suicidal ideation or plan
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness-based intervention
Participants in this arm will wear a sleep-monitoring device, complete questionnaires and participate in an online mindfulness component each week for the duration of this study.
|
Participants will complete one mindfulness education module every week for 4 weeks, and to practice a 15-minute formal guided mindfulness meditation at least five times per week across the 4 weeks.
Participants will also be taught evidence-based sleep improvement techniques, will be provided education for when to use the techniques, and will be encouraged to implement the techniques to improve sleep.
|
|
No Intervention: Control
Participants in this arm will only wear a sleep-monitoring device and complete questionnaires.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Saliva Samples via ELISA Assay- Cortisol
Time Frame: Change from baseline to 5 weeks
|
Tests for level changes in cortisol.
|
Change from baseline to 5 weeks
|
|
Saliva Samples via ELISA Assay- α-amylase
Time Frame: Change from baseline to 5 weeks
|
Test for level changes in α-amylase.
|
Change from baseline to 5 weeks
|
|
Saliva Samples via ELISA Assay- interleukin-1beta
Time Frame: Change from baseline to 5 weeks
|
Test for level changes in interleukin-1beta.
|
Change from baseline to 5 weeks
|
|
Saliva Samples via ELISA Assay- interleukin-6
Time Frame: Change from baseline to 5 weeks
|
Test for level changes in interleukin-6.
|
Change from baseline to 5 weeks
|
|
Saliva Samples via ELISA Assay- interleukin-8
Time Frame: Change from baseline to 5 weeks
|
Test for level changes in interleukin-8.
|
Change from baseline to 5 weeks
|
|
Saliva Samples via ELISA Assay- TNF-α
Time Frame: Change from baseline to 5 weeks
|
Test for level changes in TNF-α.
|
Change from baseline to 5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Change from baseline to 5 weeks
|
Assesses sleep quality.
The PSQI includes a scoring key for calculating a patient's seven sub scores, each of which can range from 0 to 3. The sub scores are tallied, yielding a "global" score that can range from 0 to 21.
A global score of 5 or more indicates poor sleep quality; the higher the score, the worse the quality.
|
Change from baseline to 5 weeks
|
|
Pittsburgh Sleep Quality Index, Addendum for PTSD (PSQI-A)
Time Frame: Change from baseline to 5 weeks
|
Assesses sleep quality related to PTSD.
The PSQI-A includes a scoring key for calculating a patient's scores, each of which can range from 0 to 3 with higher scores indicating worse outcomes.
|
Change from baseline to 5 weeks
|
|
The Smith Relaxation Dispositions Inventory
Time Frame: Change from baseline to 5 weeks
|
Assesses momentary states of relaxation during the past two weeks.
Items scored on a 4-point Likert Type scale ranging from 1 (not at all) to 4 (very much).
|
Change from baseline to 5 weeks
|
|
Five Facet Mindfulness Questionnaire - Short Form
Time Frame: Change from baseline to 5 weeks
|
Assesses 5 facets of mindfulness- observation, description, awareness of actions, non-judgement and non-reaction.
Items scored on a 5-point Likert-type scale ranging from 1 (never or very rarely true) to 5 (very often or always true).
Facet scores were computed by summing the scores on the individual items.
Facet scores range from 8 to 40 (except for the nonreactivity facet, which ranges from 7 to 35), with higher scores indicating more mindfulness.
|
Change from baseline to 5 weeks
|
|
Patient Health Questionnaire 9
Time Frame: Change from baseline to 5 weeks
|
Measures depression severity.
This is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 0- not at all, 1- several days, 2- more than half the days, 3- nearly every day, respectively.
The total score for the nine items ranges from 0 to 27. 1-4 minimal depression, 5-9 mild depression, 10-14 moderate depression, 15-19 moderately severe depression, 20-27 severe depression.
|
Change from baseline to 5 weeks
|
|
Generalized Anxiety Disorder 7
Time Frame: Change from baseline to 5 weeks
|
Assesses anxiety symptoms.
Each item is scored on a four-point Likert scale (0-3) with total scores ranging from 0 to 21 with higher scores reflecting greater anxiety severity.
Scores above 10 are considered to be in the clinical range.
|
Change from baseline to 5 weeks
|
|
Perceived Stress Scale
Time Frame: Change from baseline to 5 weeks
|
Assesses perceptions of stress.
Scores are obtained by reversing the scores on the four positive items, e.g., 0=4, 1=3, 2=2, etc. and then summing across all 10 items.
Items 4,5, 7, and 8 are the positively stated items.
|
Change from baseline to 5 weeks
|
|
Sleep Condition Indicator
Time Frame: Change from baseline to 5 weeks
|
Eight-item rating scale that was developed to screen for insomnia disorder based on DSM-5 criteria.
|
Change from baseline to 5 weeks
|
|
The PTSD Checklist for DSM-5 (PCL-5)
Time Frame: Change from baseline to 5 weeks
|
Assesses the 20 Diagnostic Statistical Manual-5 symptoms of PTSD using a 5-point Likert-type scale ranging from 0 (not at all) to 4 (extremely).
|
Change from baseline to 5 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2022
Primary Completion (Actual)
March 31, 2023
Study Completion (Actual)
March 31, 2023
Study Registration Dates
First Submitted
May 12, 2022
First Submitted That Met QC Criteria
May 17, 2022
First Posted (Actual)
May 20, 2022
Study Record Updates
Last Update Posted (Actual)
July 27, 2023
Last Update Submitted That Met QC Criteria
July 24, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- STUDY00002715
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Center for Advanced Facial Plastic SurgeryCompletedStress | Stress, Physiological | Stress Response | Stress (Psychology) | Healthy Adult Female Participants | Stress, Psychologic | Stress Perception | Stress Levels | Stress, Psychological CumulativeUnited States
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...CompletedStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Amasya UniversityCompletedThe Effect of Online Stress Management Program on Nurses' Individual Workload Perception, and StressStress | Nursing | Stress ManagementTurkey (Türkiye)
-
Canterbury Christ Church UniversitySussex Partnership NHS Foundation TrustEnrolling by invitationOccupational Stress or Workplace StressUnited Kingdom
-
University of PadovaCompletedStress | Stress Disorder | Work Related StressItaly
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
University of North Carolina, Chapel HillWashington University School of Medicine; United States Department of Defense; University of Florida and other collaboratorsRecruitingPost-traumatic Stress Disorder | Acute Stress Disorder | Acute Stress ReactionUnited States
-
K.G. Razumovsky Moscow State University of Technologies...RecruitingStress | Stress (Psychology)Russia
Clinical Trials on Mindfulness-based intervention
-
Singapore General HospitalCompletedDepression | Stroke | Stress | AnxietySingapore
-
Jordan University of Science and TechnologyCompleted
-
Hospital Miguel ServetCompleted
-
Jordan University of Science and TechnologyNot yet recruitingEnd-Stage Kidney DiseaseJordan
-
Universidad Autonoma de Baja CaliforniaEnrolling by invitationAnxiety Depression (Mild or Not Persistent)Mexico
-
IRCCS Centro San Giovanni di Dio FatebenefratelliCompleted
-
The Hong Kong Polytechnic UniversityCompleted
-
University of PisaCompletedDepression | Anxiety | Child, Only | TemperamentItaly
-
Pediatric Clinical Research PlatformActive, not recruitingCognitive Dysfunction | Preterm Birth | Behavioral Problem